Growing Cannabis Market: M&A Activity Plays Key Role; Fourth Preview of #Cannabis/ #Hemp #Stock Directory Released
Investorideas.com – February 8, 2017 – Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks, releases its fourth excerpt of its cannabis /hemp stock directory for investors following the high profile sector.
Grand View Research says “The growing number of mergers and acquisitions in the medical cannabis industry is one of the key attributes that is expected to boost the market over the coming few years. Some of the recent M&A activities in 2016 are as follows: • Nexus Corporation was acquired by Gibraltar Industries, Cannabase entered into a partnership with BioTrackTHC. ”
More info on recent M&A activity in the sector - Viridian Cannabis Deal Tracker for Week Ended 2/3/2017
U.S. medical marijuana market by application, 2013 - 2025 (USD Billion)
Marijuana/Hemp Stock List 2017
Directory Preview: Get the full list as a member at the Cannabis Directory page: http://www.investorideas.com/Marijuana-Stocks/Stocks_List.asp
NEUTRA CORPORATION (OTC:NTRR) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products.
New Age Farm Inc. (CSE: NF; OTC: NWGFF) is in the business of providing fully built out turnkey farming solutions for growers of high value luxury crops. We have operations in Washington State and British Columbia and are interested in bringing our innovative model to other jurisdictions with legalized medical and/or recreational marijuana.
Next Generation Management Corp (OTC:NGMC) focuses, primarily, on the acquisition of retail and cultivation licenses in the medical marijuana industry. The Company’s overarching strategy is to acquire lines of business that have high intrinsic future value and to generate existing, reliable revenue streams, with the medical marijuana industry being its most recent and promising direction. With this expanded direction, the Company has formed a wholly owned subsidiary, NextGen Cannabis Consulting LLC to provide management services to the high growth, high profit medical marijuana industry. NextGen Cannabis Consulting is intent on the development of a national brand that encompasses every aspect of the medical marijuana industry, including collectives, dispensaries, and grow-ops. NextGen Holdings, LLC: Next Generation Management Corporation's wholly-owned subsidiary was formed to hold its Oregon cannabis assets.
Northsight Capital Inc. (OTC:NCAP) is comprised of a portfolio of online marijuana-related websites that are being developed and operated by the company. These sites incorporate many aspects of the marijuana industry. The company provides its audience with a means to stay informed on the industry's most cutting edge marijuana-related innovations and legislation. The company's most dynamic concept, WeedDepot.com, provides consumers with a geo-targeted map directory of medical and recreational dispensaries, head shops, doctors, attorneys and more within the marijuana industry. The Weed Depot app can be downloaded for free at the iTunes Store and Google Play. Weed Depot has an entire platform of content suited for every aspect of advertising and marketing to consumers from all businesses in the cannabis industry. Northsight's current websites include: www.Weeddepot.com, www.420careers.com, www.MJBizwire.com, www.MarijuanaRecipes.com, www.RateMyStrain.com, www.WikiWeed.com, www.MarijuanaMd.com, and www.MarijuanaHealthTips.com
Notis Global, Inc (OTC:NGBL) Based in Los Angeles, Notis Global is a pioneer in the burgeoning, multi-billion dollar legal hemp industry. The Company and its partners are working to grow confidence and generate revenues in the hemp industry. Through our key partnership with Folium Biosciences, one of the largest hemp operations in the U.S., Notis is a leading provider and distributor of cannabidiol (CBD).
NOVUS Acquisition & Devleopment Corp. (OTC:NDEV) provides health insurance and related insurance solutions to the medical marijuana industry in states where legal programs exist. The Company also plans to offer physicians' education programs, pharmaceutical R&D, compliance, and business development services within the industry.
Nutritional High International Inc. (CSE:EAT; OTCQB:SPLIF; FRANKFURT:2NU.F) is focused on developing, manufacturing and distributing products and nationally recognized brands in the hemp and marijuana-infused products industries, including edibles and oil extracts for nutritional, medical and adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.
Omnicanna Health (formerly Endocan) (OTC:ENDO) is currently developing new natural cannabis-based products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis and hemp have been known and applied for thousands of years. With the aid of scientific research, OmniCanna Health Solutions is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.
OrganiGram Holdings Inc. (TSX:OGI.V) wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.
OWC Pharmaceutical Research Corp. (OTC:OWCP) through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., (collectively \"OWC\" or the \"Company\") conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWC is also developing unique delivery systems for the effective delivery and dosage of medical cannabis. All OWC research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators. The Company's Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids for the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.
Pazoo, Inc. (OTC:PZOO) is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly owned subsidiary, Harris Lee, and our partnership with MA & Associates, Pazoo provides industry leading laboratory testing of cannabis. Pazoo's license agreement with Steep Hill Labs Inc. allows us to use their best-in-market testing protocols on a right of first refusal basis as we expand throughout the USA. Pazoo is licensed to test cannabis in Nevada and Oregon, with a focus on expansion into other states. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its website www.pazoo.com, and features industry experts from both the health and wellness arena and the pet industry.
Bioetchis a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box® This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. PharmaCyte Biotech's treatment for pancreatic cancer involves low doses of the well-known anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or "cancer-killing" form. These capsules are placed as close to the cancerous tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. This "targeted chemotherapy" has proven remarkably effective in past clinical trials. In addition, PharmaCyte Biotech is working towards improving the quality of life for patients with advanced pancreatic cancer and on treatments for other types of solid cancerous tumors. PharmaCyte Biotech is also developing treatments for cancer based upon chemical constituents of marijuana known as cannabinoids. In doing so, PharmaCyte Biotech is examining ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects usually associated with cancer treatments. This provides PharmaCyte Biotech the rare opportunity to develop "green" approaches to fighting deadly diseases, such as cancer of the pancreas, brain and breast, which affect hundreds of thousands of individuals worldwide every year.
Pineapple Express Inc. (OTC:PNPL) Headquartered in Los Angeles, Calif., Pineapple Express is a publicly traded company that invests in, expands, and brands existing and newly established canna-businesses through expert consulting and cutting-edge technology. We provide capital to our canna- business clientele, lease real properties to canna-businesses, and provide consulting and technology to operators within the cannabis industry. We intend to create a nationally branded chain of company owned cannabis retail stores under the "Pineapple Express" name, as soon as federal laws allow. As long as cannabis remains federally illegal our operations will be limited to consulting, product licensing, leasing to and investing in existing and new canna-businesses, selling industry specific technology, and branding/retail concept support services. Home to some of the most experienced and well-connected minds in the business, Pineapple Express is at the forefront of the legal cannabis industry.
Plandaí Biotechnology, Inc. (OTC:PLPL) and its subsidiaries develop highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare™ extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and pharmaceutical.
Players Network Inc (OTC:PNTV) is a diversified company with holdings in Media and Medical Marijuana. The Company uses its proprietary Enterprise Web Platform to develop Branded Digital Lifestyle Television Networks for itself and its partners in a wide range of lifestyle categories. Player's Network's current original channels, "Player's Network," "Vegas on Demand," "Real Vegas TV," focus on the Las Vegas and Gaming Lifestyles. These channels are distributed over PNTV's owned and operated VOD Channels over its Broadband Network and Mobile Platforms. The Medical Marijuana assets are primarily through the Company's 86% ownership in Greenleaf Farms Holdings, and PNTV's newest channel, WeedTV.com, which focuses on the rapidly expanding cannabis community.
Profile Solutions, Inc. (OTC:PSIQ) designs, manufactures and sells security-based identification products and systems that incorporate state-of-the-art security technology to verify a person's identity, or grant physical access. PSI has developed turnkey integrated applications that incorporate our proprietary Access-It hardware platform. We also integrate our applications with biometric technology for additional security when required. PSI targets the law enforcement, cannabis industry and corporate America as our customer base.
PUF Ventures Inc. (CSE:PUF) is moving into the Medical Marijuana sector by purchasing a 100% interest in AAA Heidelberg, a private Ontario company that is in the process of applying for a MMPR license. Although the Company cannot guarantee nor estimate the timing for the issuance of a license to AAA Heidelberg, it is PUF’s goal to become the next publicly traded Canadian company to be granted a new medical marijuana production license. VapeTronix, a wholly owned subsidiary of the Company, is in the process of expanding its 1313 brand of electronic cigarettes and associated technologies.
Puget Technologies, Inc. (OTC: PUGE) is a development-stage company. The Company is engaged in developing and marketing of consumer-oriented products ready for commercialization. The Company's subsidiaries include B-29 Energy, Inc. (B-29), which is in the development stage. B-29 is engaged in the business of development and distribution of energy products. B-29's products include B-29 Energy Drink and various medical marijuana products, which are under development. B-29 produces these products through its subsidiary, Cannabis Biotech. The Company is also engaged in the development of three dimensional (3D) printing and supporting technologies for My3DP personal printer. The applications of the Company's products are in various sectors, which include crafting, jewelry and domestic goods.
Radient Technologies Inc. (TSX:RTI.V) extracts natural compounds from a range of biological materials using microwave assisted processing ("MAP™"), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its 20,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health, personal care and biofuel markets. Marijuana – November 14 press release announces foray in the fast emerging cannabinoids medical market.
is a developer and reseller of herbal vaporizers. The core strategy is to maximize revenues in the rapidly expanding medical cannabis and vaporizer industries. Rapid Fire Marketing also looks to invest and do joint ventures with companies in the vaporizer and medical cannabis industries as well as working with other companies with established revenue streams that are looking to grow their businesses. Rapid Fire Marketing is also looking to grow through acquisitions of companies or technologies that are synergistic with our business plan.
RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) is a leader in the development of medicines for respiratory disorders, with a focus on sleep apneas and drug-induced respiratory depression. The Company holds exclusive licenses and owns patents and patent applications or rights thereto for certain families of chemical compounds that claim the chemical structures and their uses in the treatment of a variety of disorders, as well as claims for novel uses of known drugs. RespireRx has a pipeline of medicines in Phase 2 clinical development focused on pharmaceutical treatments for a variety of breathing disorders. Clinical development in the area of respiratory disorders, particularly drug-induced respiratory depression and sleep apnea, has created opportunities for the development and commercialization of the Company's compounds. Cannabinoids. One platform being developed by RespireRx is the class of compounds known as cannabinoids, including dronabinol. Under a license agreement with the University of Illinois, the Company has rights to patents claiming the use of cannabinoids for the treatment of sleep-related breathing disorders. Ampakines. The other platform of proprietary medicines being developed by RespireRx are ampakines, which act to enhance the actions of the excitatory neurotransmitter glutamate at AMPA glutamate receptors. Several ampakines, in both oral and injectable forms, are being developed by the Company for the treatment of a variety of breathing disorders. In clinical studies, select ampakines have shown preliminary efficacy in central sleep apnea and in the control of respiratory depression produced by opioids, without altering the opioid analgesic effects. In animal models of orphan disorders, such as Pompe Disease, spinal cord injury and perinatal respiratory distress, it has been demonstrated that certain ampakines improve breathing function. The Company's compounds belong to a new class that does not display the undesirable side effects previously reported for other ampakines.
Rocky Mountain High Brands Inc (OTC:RMHB) is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low-calorie Coconut Lime Energy drink. Rocky Mountain High Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy Shots, as well as a new Relaxation Brownie. The Company recently launched a naturally high alkaline spring water, Eagle Spirit Spring Water™.
Get the full list as a member at the Cannabis Directory page: http://www.investorideas.com/Marijuana-Stocks/Stocks_List.asp
This directory is for research purposes and not a solicitation to buy or sell securities.
To be added to the directory or update your description, please call or email us.
About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.
Sectors we cover in include tech, bitcoin and blockchain , biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security including biometrics, Latin America, sports, entertainment, luxury brands and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow stocks in your favourite stock sector including marijuana and hemp stocks with Investor Ideas stock directories
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. PSIQ is a paid PR and news client on Investorideas – more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Marijuana / Hemp Stocks
Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Global Cannabis Investing - features Investor Ideas Cannabis news